Astrocyte dopamine D1 receptor signaling in depression
Major depressive disorders (MDD) represent a global challenge. Although many recent initiatives have resulted in new antipsychotic drugs, their efficacy is not optimal. One possible reason for this is that the prevailing paradigm...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ASTRO_ECM
Deciphering the role of astrocytes in chronic depression.
159K€
Cerrado
PSI2015-73408-JIN
REVIRTIENDO LAS AFECCIONES DEL TRAUMA A TRAVES DEL LENGUAJE
134K€
Cerrado
SchizoFree
Understanding and manipulating the dysregulation of interneu...
213K€
Cerrado
GONOGO
Multi layered integration of motivated actions and their out...
188K€
Cerrado
PID2020-118511RB-I00
DINAMICA DE LOS AGREGADOS MACROMOLECULARES DE HETERORECEPTOR...
321K€
Cerrado
PSYNegrT
Deciphering the Negr1 interacting network in physiological c...
183K€
Cerrado
Información proyecto D1-Glia
Duración del proyecto: 23 meses
Fecha Inicio: 2023-04-01
Fecha Fin: 2025-03-31
Líder del proyecto
UNIVERZA V LJUBLJANI
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Major depressive disorders (MDD) represent a global challenge. Although many recent initiatives have resulted in new antipsychotic drugs, their efficacy is not optimal. One possible reason for this is that the prevailing paradigm for drug development is based on the neuron-centric view of how the central nervous system (CNS) copes with diseases. In the fellowship, I will study neuroglia, the nonneuronal cells responsible mainly for maintaining homeostasis in the CNS. Failure in the function of these cells can set the course for neurological conditions, including psychiatric diseases and MDD. Thus, targeting neuroglia has recently been viewed as a new translational ground for drug development. The present proposal is therefore based on our understanding of the potential role of neuroglia in brain disease. One of the major neurotransmitters, dopamine, is known to play an important role in MDD. I will examine the regulation of astrocytes, a major type of neuroglia, by dopamine. Based on the state of the art, I hypothesise that astrocytic dopamine D1 receptor signalling may be involved in the pathophysiology of MDD. Through innovative methodological approaches I will study the regulation of astrocytic D1 receptor signalling at the cellular level in an experimental model of MDD. Moreover, this project will explore D1 signalling in vivo to validate the results obtained on isolated cells. The proposed research will provide a new framework that includes astrocytes and the mechanisms underlying the dopaminergic modulation in depression. This will afford novel cellular targets for treatment of MDD associated with dopamine D1 receptor signalling. In addition, a comprehensive two-way transfer of knowledge is envisioned to bring together competences and experiences necessary for the proposed research. The fellowship will facilitate my career development and enable me to get established in the field.